Antimicrobial drug resistance: 1 Mechanisms of drug resistance
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
New York, NY
Humana Press
2009
|
| Schriftenreihe: | Infectious disease
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis Klappentext |
| Beschreibung: | XXVI, 678 S. Ill., graph. Darst. |
| ISBN: | 9781603275927 9781597451802 |
Internformat
MARC
| LEADER | 00000nam a2200000 cc4500 | ||
|---|---|---|---|
| 001 | BV035381805 | ||
| 003 | DE-604 | ||
| 005 | 20090916 | ||
| 007 | t | ||
| 008 | 090319s2009 ad|| |||| 00||| eng d | ||
| 020 | |a 9781603275927 |9 978-1-60327-592-7 | ||
| 020 | |a 9781597451802 |9 978-1-59745-180-2 | ||
| 035 | |a (OCoLC)436260573 | ||
| 035 | |a (DE-599)BVBBV035381805 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-19 |a DE-20 | ||
| 050 | 0 | |a QR177 | |
| 082 | 0 | |a 616.9041 |2 22 | |
| 245 | 1 | 0 | |a Antimicrobial drug resistance |n 1 |p Mechanisms of drug resistance |c ed. by Douglas L. Mayers |
| 264 | 1 | |a New York, NY |b Humana Press |c 2009 | |
| 300 | |a XXVI, 678 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Infectious disease | |
| 650 | 4 | |a Anti-infective agents | |
| 650 | 4 | |a Drug Resistance |x physiology | |
| 650 | 4 | |a Drug Resistance, Microbial | |
| 650 | 4 | |a Drug resistance in microorganisms | |
| 700 | 1 | |a Mayers, Douglas L. |e Sonstige |4 oth | |
| 773 | 0 | 8 | |w (DE-604)BV035381800 |g 1 |
| 856 | 4 | 2 | |m Digitalisierung UB Regensburg |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017186052&sequence=000003&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 856 | 4 | 2 | |m Digitalisierung UB Regensburg |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017186052&sequence=000004&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA |3 Klappentext |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-017186052 | ||
Datensatz im Suchindex
| _version_ | 1804138711657480192 |
|---|---|
| adam_text | Table
of Contents
Antimicrobial Drug Resistance
Volume
1
Section A General Overview
Douglas L. Mayers
1
History of Drug-Resistant Microbes
.................................................................... 3
George A. Jacoby
2
Evolutionary Biologyof Drug Resistance
........................................................... 9
Fernando Baquero and Rafael Canton
3
Pharmacology of Drug Resistance
....................................................................... 33
G.L. Drusano
4
Antimicrobial Resistance Versus the Discovery
and Development of New Antimicrobials
............................................................ 43
David M. Shlaes and Steven J. Projan
Section
В
General Mechanisms of Drug Resistance
Stephen A.
Lerner
5
Genetic Mechanisms of Transfer of Drug Resistance
........................................ 53
Paul H. Roy
6
Mutations as a Basis of Antimicrobial Resistance
............................................. 65
Maja
Babic
and Robert A. Bonomo
7
Target-Mediated Antibacterial Resistance
......................................................... 75
Louis B. Rice
8
Biochemical Logic of Antibiotic Inactivation and Modification
....................... 81
Vanessa
D
Costa and Gerard D. Wright
9
Antibiotic Resistance Due to Reduced Uptake
................................................... 97
Joseph B. McPhee, Sandeep Tamber, Michelle D.
Brazas,
Shawn Lewenza, and Robert E.W. Hancock
10
Transport Mechanisms of Resistance to Drugs and Toxic Metals
.................... 111
Adrian R. Walmsley and Barry P. Rosen
11
The Functional Resistance of Bacterial
Biofilms
................................................ 121
Christoph
A. Fux, Paul Stoodley, Mark
Shirtlíff,
and J. William Costerton
vii
vj¡¡
Contents
Section C
Bacterial
Drug Resistance
-
Mechanisms
Stephen A.
Lerner
12
The Importance of
ß-Lactamases
to the
Development of New
ß-Lactams........................................................................... 135
Karen Bush
13
Penicillin-Binding Proteins and
ß-Lactam
Resistance
........................................ 145
André
Zapun, Pauline Macheboeuf
,
and Thierry
Vernét
14
Aminoglycosides: Mechanisms of Action and Resistance
.................................. 171
Maria L.
Magalhães
and John
S. Blanchard
15
Tetracycline and Chloramphenicol Resistance Mechanisms
............................. 183
Marilyn C. Roberts and Stefan
Schwarz
16
Fluoroquinolone Resistance in Bacteria
.............................................................. 195
Varsha V. Moudgal and Glenn W. Kaatz
17
Plasmid-Mediated Quinolone Resistance
............................................................ 207
George A. Jacoby
18
Macrolides and Lincosamides
............................................................................... 211
Annie Canu and Roland Leclercq
19
Mechanism of Resistance in Metronidazole
........................................................ 223
Abhay Dhand and David R. Snydman
20
Glycopeptide Resistance in Enterococci
.............................................................. 229
Bruno
Périchon
and Patrice Courvalin
21
Streptogramin
......................................................................................................... 241
Kimberly D. Leuthner and Michael J.
Rybak
22
Resistance to Linezolid
.......................................................................................... 247
Dean Shinabarger and George M. Eliopoulos
23
Sulfonamides and Trimethoprim
.......................................................................... 259
Ola Sköld
24
Mechanisms of Action and Resistance of Antimycobacterial Agents
............... 271
Petros C. Karakousis
Section
D
Fungal Drug Resistance
-
Mechanisms
Jack D.
Sobel
25
Amphotericin
B: Polyene
Resistance Mechanisms
............................................. 295
Elizabeth M. O Shaughnessy, Caron A. Lyman, and Thomas J. Walsh
26
Fungal Drug Resistance: Azoles
........................................................................... 307
Jose L. Lopez-Ribot and Thomas F. Patterson
27
Flucytosine: Site of Action, Mechanism of Resistance
and Use in Combination Therapy
........................................................................ 313
Jyotsna Chandra, Sotohy Mohammad, and
Mahmoud
A. Ghannoum
28
Echinocandins: Exploring Susceptibility and Resistance
.................................. 327
Cameron M. Douglas
29
Antifunga!
Targets, Mechanisms of Action,
and Resistance in Candida albimns
...................................................................... 347
Robert A. Akins and Jack D.
Sobel
Contents
¡χ
Section
E
Viral
Drug Resistance
-
Mechanisms
Douglas L. Mayers
30
Mechanisms of Resistance of Antiviral Drugs Active
Against the Human Herpes Viruses
..................................................................... 411
Clyde S. Crumpacker
31
Influenza M2 Ion-Channel and Neuraminidase Inhibitors
................................ 421
Margaret Tisdale
32
Molecular Mechanisms of Resistance
to Nucleoside Reverse Transcriptase Inhibitors
.................................................. 449
Marleen
C.D.G.
Huigen
and Charles
A.B.
Boucher
33
Resistance to
HIV
Non-Nucleoside Reverse
Transcriptase Inhibitors
........................................................................................ 461
Robert Elston and Pierre R. Bonneau
34
Resistance to HIV-1 Protease Inhibitors
.............................................................. 477
Louise Doyon, Robert Elston, and Pierre R. Bonneau
35
Resistance to Enfuvirtide and Other
HIV
Entry Inhibitors
.............................. 493
Thomas
Melby,
Gábriellé
Heilek, Nick Cammack,
and Michael L.
Greenberg
36
Resistance to Inhibitors of Human Immunodeficiency
Virus Type I Integration
........................................................................................ 507
Daria J.
Hazuda
37
The Hepatitis
В
Virus and Antiviral Drug Resistance:
Causes, Patterns, and Mechanisms
...................................................................... 519
Stephen Locarnini
38
Mechanisms of Hepatitis
С
Virus Drug Resistance
............................................ 531
Samir AH and George
Kukolj
Section
F
Parasitic Drug Resistance
-
Mechanisms
Marc Ouellette
39
Drug Resistance Mechanisms in Entamoeba histolytica,
Giardia
lamblia,
Trichomonas
vaginalis,
and Opportunistic
Anaerobic Protozoa
................................................................................................ 549
Esther Orozco, Laurence
A. Marchât,
Consuelo Gómez,
César López-Camarillo, and D. Guillermo Pérez
40
Mechanisms of Antimalarial Drug Resistance
.................................................... 561
Giancarlo A. Biagini, Patrick G. Bray, and Stephen A. Ward
41
Drug Resistance mLeishmania
............................................................................. 575
Hiranmoy Bhattacharjee and Rita Mukhopadhyay
42
Drug Resistance in African Trypanosomiasis
..................................................... 589
Thomas Seebeck and Pascal
Maser
43
Drug Resistance and Emerging Targets in the Opportunistic
Pathogens Toxoplasma gondii and Cryptosporidium parvum
.............................. 605
Boris Striepen
44
Drug Resistance in Nematodes
............................................................................. 621
Roger Prichard
Contents
45
Chemotherapy and Drag Resistance in Schistosomiasis,
Fascioliasis and Tapeworm Infections
.................................................................. 629
Michael J. Doenhoff, Gerald C. Coles, Livia Pica-Mattoccia,
and
Katherine
Wheatcroft-Francklow
46
Drug Resistance in Ectoparasites of Medical
and Veterinary Importance
................................................................................... 647
Kathryn Stafford and Gerald Coles
Index
................................................................................................................................ 655
Table of Contents
Antimicrobial Drug Resistance
Volume
2
Section
G
Gram-Positive Bacterial Drug Resistance
-
Clinical
Stephen A.
Lerner
47
Resistance in Streptococcus pneumoniae
.............................................................. 681
Lesley McGee and Keith P. Klugman
48
Antibiotic Resistance of Non-Pneumococcal Streptococci
and Its Clinical Impact
.......................................................................................... 695
Jari
Jalava and Helena
Seppälä
49
Enterococcus: Antimicrobial Resistance in Enterococci
Epidemiology, Treatment, and Control
................................................................ 715
Anne Y. Chen and Marcus J. Zervos
50
Antimicrobial Resistance in Staphylococci: Mechanisms
of Resistance and Clinical Implications
............................................................... 735
Lisa G. Winston and Henry
R
Chambers
51
Resistance in Aerobic Gram-Positive Bacilli
....................................................... 749
David J. Weber and William A. Rutala
Section
H
Gram-Negative Bacterial Drug Resistance
-
Clinical
Stephen A.
Lerner
52
Antibiotic Resistance in Neisseria
......................................................................... 763
Margaret C. Bash, Durrie L. McKnew, and John W. Tapsall
53
Mechanisms of Resistance in Haemophilus
influenzáé
and Moraxella catarrhalis
...................................................................................... 783
Michael R. Jacobs
54
Enterobacteriaceae
.................................................................................................. 803
David L. Paterson
55
Pseudomonas aeruginosa
....................................................................................... 811
David L. Paterson and Baek-Nam Kim
56
Acinetobacter
...........................................................................................................
gjo
David L. Paterson and Anton Y. Peleg
Contents xi
57
Antimicrobial
Resistance ofShigella spp.,
Typhoid Salmonella
and Nontyphoid Salmonella
.................................................................................. 825
Herbert
L. DuPont
58
Antimicrobial
Resistance in
Vibrios.....................................................................
833
Michael
L.
Bennish, Wasif
A. Khan, and
Debasish Saha
59
Antimicrobial
Resistance in Helicobacter and Campylobacter........................... 847
Patrick F. McDermott, Joanne L. Simala-Grant,
and Diane E. Taylor
60
Pertussis (Whooping Cough)
................................................................................. 865
Michael
Α.
Saubolle
61
Antibiotic
Resistance
of Anaerobic Bacteria
....................................................... 873
Itzhak
Brook
62
Mycobacteria: Tuberculosis
.................................................................................. 901
Francis A. Drobniewski and Yanina Balabanova
63
Drug Resistance by Non-Tuberculous Mycobacteria
......................................... 917
Kathleen Horan and Gerard A. Cangelosi
Section I Fungal Drug Resistance
-
Clinical
Jack D.
Sobel
64
The Role of Resistance in Candida Infections:
Epidemiology and Treatment
................................................................................ 931
J.D.
Sobel
and R.A. Akins
65
Antifungal Resistance: Aspergillus
....................................................................... 953
P.H. Chandrasekar and
Elias
К.
Manavathu
66
Drug Resistance in Cryptococcus neoformans
..................................................... 967
Kimberly E. Hanson, Barbara D. Alexander, and John Perfect
67
Antifungal Drug Resistance in Histoplasmosis
................................................... 987
L. Joseph Wheat, Patricia Connolly,
Melinda
Smederna,
and P. David Rogers
68
Drug Resistance in Pneumocystis jirovedi
........................................................... 993
Jannik Helweg-Larsen, Thomas Benfield, Joseph
Kovács,
and Henry Masur
Section
J
Viral Drug Resistance
-
Clinical
Douglas L. Mayers
69
Antiviral Resistance in Influenza Viruses:
Clinical and Epidemiological Aspects
.................................................................. 1011
Frederick G. Hayden
70
Herpesvirus Resistance
.......................................................................................... 1035
G. Boivin and W.L. Drew
71
Clinical Implications of HIV-1 Drug Resistance
................................................. 1049
Douglas L. Mayers
72
Clinical Implications of Resistance for Patients
with Chronic Hepatitis
В
....................................................................................... 1061
Nathaniel A. Brown
xjj
Contents
Section
К
Parasitic Drug Resistance
-
Clinical
Marc Ouellette
73
Antimalarial Drug Resistance: Clinical Perspectives
......................................... 1077
Philip J.
Rosenthal
74
Diagnosis and Treatment of Metronidazole-Resistant
Trichomonas
vaginalis
Infection
........................................................................... 1091
Sarah L. Cudmore and Gary E. Garber
75
Drug Resistance in Leishmania: Clinical Perspectives
....................................... 1101
Shyam Sundar and Madhukar
Rai
76
Human African Trypanosomiasis
......................................................................... 1113
Jacques
Pépin
and
Honoré
Méda
77
Drug Resistance in Toxoplasma gondii
................................................................. 1121
Paul EG. Sims
78
Drug Resistance in the Sheep Nematode Parasite
Haemonchus contortus, Mechanisms and Clinical Perspectives
........................ 1127
Marleen
H.
Roos
Section
L
Measurements of Drug Resistance
Douglas L. Mayers
79
In Vitro Performance and Analysis of Combination
Anti-infective Evaluations
..................................................................................... 1135
Robert W. Buckheit and R. Dwayne Lunsford
80
Antimicrobial Susceptibility Testing Methods
for Bacterial Pathogens
......................................................................................... 1151
Fred C. Tenover
81
Drug Resistance Assays for Mycobacterium tuberculosis
................................... 1161
Leonid Heifets and Gerard Cangelosi
82
Fungal Drug Resistance Assays
............................................................................ 1171
Sevtap Arikan and John H. Rex
83
Viral Phenotypic Resistance Assays
..................................................................... 1187
Neil Parkin
84
Drug Resistance Assays for Parasites
................................................................... 1201
N.C. Sangster, G.N. Maitland, S. Geerts,
Saskia
Decuypere,
Jean-Claude Dujardin, J.A. Upcroft, P. Upcroft, and M. Duraisingh
85
Genotypie
Drug Resistance Assays
....................................................................... 1227
A. Huletsky and M.G. Bergeron
86
The Use of
Genotypie
Assays for Monitoring
the Development of Resistance to Antiviral Therapy
for HIV-1 Infection and Other Chronic Viral Diseases
...................................... 1249
Jorge L. Martinez-Cajas, Marco Petrella, and Mark A. Wainberg
Contents
χϋί
Section M Public Health Issues
of Drug Resistance
Douglas
L.
Mayers
87
Antimicrobial Resistance: An International
Public Health Problem
.......................................................................................... 1267
Carlos A. DiazGranados and John E. McGowan, Jr.
88
Hospital Infection Control: Considerations for the
Management and Control of Drug-Resistant Organisms
.................................. 1277
Gonzalo M.L.
Bearman and Richard P.
Wenzel
89
Controlling the Spread of Resistant Pathogens
in the Intensive Care Unit
..................................................................................... 1295
David K. Henderson
90
Implications of Antibiotic Resistance in
Potential Agents of
Bioterrorism
.......................................................................... 1315
Linda M. Weigel and Stephen A. Morse
91
Internet Resources on Antimicrobial Resistance
................................................ 1339
Matthew E. Falagas Efthymia A. Karveli
Index
................................................................................................................................ 1347
Infectious Disease Vassil St.
Georgiev,
Series Editor
Antimicrobial Drug Resistance
Volume
1,
Mechanisms of Drug Resistance
Edited by
Douglas L. Mayers
Idenix Pharmaceuticals, Cambridge, MA
Section Editors: Stephen A.
Lerner,
Marc Ouellette, Jack D.
Sobel
The volumes included in Antimicrobial Drug Resistance represent the first comprehensive, multidisciplinary
reference covering the area of antimicrobial drug resistance in bacteria, fungi, viruses, and parasites from
basic science, clinical, and epidemiological perspectives.
The first volume, Antimicrobial Drug Resistance, Mechanisms of Drug Resistance, is dedicated to the biological
basis of drug resistance and effective avenues for drug development. With the emergence of more drug-
resistant strains, the approach to dealing with the drug resistance problem must include the research of
different aspects of the mechanisms of bacterial resistance and the dissemination of resistance genes as
well as research utilizing new genomic information. These approaches will permit the design of novel
strategies to develop new antibiotics and preserve the effectiveness of currently available ones.
The second volume, Antimicrobial Drug Resistance, Clinical and Epidemiological Aspects, is devoted to the
clinical aspects of drug resistance. Although there is evidence that restricted use of a specific antibiotic can
be followed by a decrease in drug resistance to that agent, drug resistance control is not easily achieved.
Thus, the infectious disease physician requires input from the clinical microbiologist and infection control
specialist to make informed choices for the effective treatment of various strains of drug-resistant
pathogens in individual patients.
This 2-volume set is an important reference for students in microbiology, infectious disease physicians,
medical students, basic scientists, drug development researchers, microbiologists, epidemiologists,
and public health practitioners.
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV035381805 |
| callnumber-first | Q - Science |
| callnumber-label | QR177 |
| callnumber-raw | QR177 |
| callnumber-search | QR177 |
| callnumber-sort | QR 3177 |
| callnumber-subject | QR - Microbiology |
| ctrlnum | (OCoLC)436260573 (DE-599)BVBBV035381805 |
| dewey-full | 616.9041 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.9041 |
| dewey-search | 616.9041 |
| dewey-sort | 3616.9041 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01631nam a2200385 cc4500</leader><controlfield tag="001">BV035381805</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20090916 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">090319s2009 ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781603275927</subfield><subfield code="9">978-1-60327-592-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781597451802</subfield><subfield code="9">978-1-59745-180-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)436260573</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV035381805</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-20</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QR177</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.9041</subfield><subfield code="2">22</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Antimicrobial drug resistance</subfield><subfield code="n">1</subfield><subfield code="p">Mechanisms of drug resistance</subfield><subfield code="c">ed. by Douglas L. Mayers</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York, NY</subfield><subfield code="b">Humana Press</subfield><subfield code="c">2009</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XXVI, 678 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Infectious disease</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anti-infective agents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Resistance</subfield><subfield code="x">physiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Resistance, Microbial</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug resistance in microorganisms</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mayers, Douglas L.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="w">(DE-604)BV035381800</subfield><subfield code="g">1</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung UB Regensburg</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017186052&sequence=000003&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung UB Regensburg</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017186052&sequence=000004&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Klappentext</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-017186052</subfield></datafield></record></collection> |
| id | DE-604.BV035381805 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T21:32:32Z |
| institution | BVB |
| isbn | 9781603275927 9781597451802 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-017186052 |
| oclc_num | 436260573 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-19 DE-BY-UBM DE-20 |
| owner_facet | DE-355 DE-BY-UBR DE-19 DE-BY-UBM DE-20 |
| physical | XXVI, 678 S. Ill., graph. Darst. |
| publishDate | 2009 |
| publishDateSearch | 2009 |
| publishDateSort | 2009 |
| publisher | Humana Press |
| record_format | marc |
| series2 | Infectious disease |
| spelling | Antimicrobial drug resistance 1 Mechanisms of drug resistance ed. by Douglas L. Mayers New York, NY Humana Press 2009 XXVI, 678 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Infectious disease Anti-infective agents Drug Resistance physiology Drug Resistance, Microbial Drug resistance in microorganisms Mayers, Douglas L. Sonstige oth (DE-604)BV035381800 1 Digitalisierung UB Regensburg application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017186052&sequence=000003&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis Digitalisierung UB Regensburg application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017186052&sequence=000004&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA Klappentext |
| spellingShingle | Antimicrobial drug resistance Anti-infective agents Drug Resistance physiology Drug Resistance, Microbial Drug resistance in microorganisms |
| title | Antimicrobial drug resistance |
| title_auth | Antimicrobial drug resistance |
| title_exact_search | Antimicrobial drug resistance |
| title_full | Antimicrobial drug resistance 1 Mechanisms of drug resistance ed. by Douglas L. Mayers |
| title_fullStr | Antimicrobial drug resistance 1 Mechanisms of drug resistance ed. by Douglas L. Mayers |
| title_full_unstemmed | Antimicrobial drug resistance 1 Mechanisms of drug resistance ed. by Douglas L. Mayers |
| title_short | Antimicrobial drug resistance |
| title_sort | antimicrobial drug resistance mechanisms of drug resistance |
| topic | Anti-infective agents Drug Resistance physiology Drug Resistance, Microbial Drug resistance in microorganisms |
| topic_facet | Anti-infective agents Drug Resistance physiology Drug Resistance, Microbial Drug resistance in microorganisms |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017186052&sequence=000003&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017186052&sequence=000004&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV035381800 |
| work_keys_str_mv | AT mayersdouglasl antimicrobialdrugresistance1 |